FDAHealthApril 25, 2025
Mckesson Medical-Surgical Inc. Corporate Office — Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 0
⚠️ Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Is this relevant to me?
- Geography
- MS, FL
- Source agency
- FDA
- Category
- Health
- Published
- April 25, 2025
Distributed to Medical Facilities in MS and FL.
What's affected?
- Product
- Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
- Lot code
- 1MP24042
Additional details
Lot #: 1MP24042, Exp 6/30/26
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 3.
Get Health recall alerts
Delivered to your inbox. Free. No account required.